Skip to content

Nicole D. Fitzgerald

5 papers in the library · 16 citations · publishing 2023-2025

Papers

Sort Most recent Most cited

The Epidemiology of Recreational Use and Availability of DOC and DOI in the United States

Journal of Psychoactive Drugs October 9, 2025 Joseph J Palamar, Nicole D. Fitzgerald 2 citations

The U.S. Drug Enforcement Administration (DEA) proposed a rule in which they intend to place the psychedelic phenethylamines 2,5-dimethoxy-4-chloroamphetamine (DOC) and 2,5-dimethoxy-4-iodoamphetamine (DOI) into Schedule I of the Controlled Substances Act. We investigated the epidemiology of use and availability of these substances. We investigated national trends in seizures of these compounds...

DOI: 10.1080/02791072.2025.2570937 (opens in new tab) Epidemiology Recreational use Poison control Recreational drug use +7

An Update on the Epidemiology of Tusi ("Pink Cocaine").

Current Addiction Reports 2025 Nina Abukahok, Nicole D. Fitzgerald, Joseph J Palamar

Tusi, also known as "pink cocaine," has emerged across nightlife scenes in Latin America, Europe, Australia, and the United States (US). Tusi is typically a drug mixture containing ketamine and 3,4-methylenedioxymethamphetamine (MDMA). Due to tusi's inconsistent chemical makeup, surveillance and harm reduction efforts have proven difficult for researchers and consumers alike. This review...

National and regional trends in seizures of shrooms (psilocybin) in the United States, 2017-2022.

Drug and Alcohol Dependence May 1, 2024 Joseph J Palamar, Nicole D. Fitzgerald, Thomas H Carr et al. 9 citations

Psilocybin, the principle psychoactive component in "shrooms", is regaining acceptance in therapeutic settings, leading to media coverage of medical benefits associated with use. Possession is also becoming increasingly decriminalized throughout the United States. There is a lack of data on prevalence of shroom use, but trends in law enforcement seizure data can provide one indicator of shroom...

DOI: 10.1016/j.drugalcdep.2024.111086 (opens in new tab) Full text (opens in new tab) Drug laws Drug seizures Psilocybin mushrooms Law enforcement surveillance +2

Increases in the use of drug testing kits among nightclub and festival attendees in New York City who use ecstasy, 2017-2022.

Drug and Alcohol Review May 1, 2024 Nicole D. Fitzgerald, Joseph J Palamar 5 citations

Ecstasy (3,4-methylenedioxymethamphetamine [MDMA]) is a drug commonly used by people who attend electronic dance music (EDM) events at nightclubs and dance festivals. Drug checking has gained popularity in recent years to test for adulterants, but epidemiology studies are needed to estimate potential shifts in prevalence of drug checking to further inform harm reduction efforts. Adults entering...

Characteristics of poisonings involving ketamine in the United States, 2019-2021.

Journal of Psychopharmacology August 2023 Joseph J Palamar, Nicole D. Fitzgerald, David J Grundy et al.

The use of ketamine, a controlled dissociative anesthetic, has become more widespread in recent years with recreational/nonmedical use increasing and ketamine becoming more widely available in clinics to treat depression. We examined recent trends in adverse effects related to ketamine use. US National Poison Control data were examined, focusing on ketamine exposures among those aged ⩾13...